Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography Versus MRI
| Status: | Recruiting |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - 95 |
| Updated: | 11/8/2014 |
| Start Date: | November 2003 |
| Contact: | Rebecca Knoff, RN |
| Email: | rebecca.knoff@emoryhealthcare.org |
| Phone: | 404-686-1825 |
Comparison of Myocardial Viability by Positron Emission Tomography Versus Contrast-Enhanced Cardiac Magnetic Resonance Imaging
The purpose of this study is to compare cardiac MRI with positron emission tomography (PET)
with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better,
than PET with FDG.
with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better,
than PET with FDG.
Inclusion Criteria:
- PET with FDG ordered
Exclusion Criteria:
- Contraindicated for MRI
We found this trial at
1
site
Click here to add this to my saved trials
